we are providing drug development services. early phase development of nce, intermediates or key starting materials for toxicity studies and for clinical phasesupplies by process research, development and supply of material along with gmp/cmc documentation suitable for thephase. isll is equipped with state of art r&d, process research & development, kilo labs, pilot plant and manufacturingplants appropriately accredited by various global authorities including us fda, edqm, tga, pmda, who gmp etc.